Pathogen Interference: Targeting Virulence Factors to Tackle Intracellular Microbes

Area of Science:

• Microbiology
• Chemical Biology
• Drug Discovery

Background:

• Salmonella enterica infections present significant challenges for antibiotic treatment due to increasing resistance.
• Intracellular bacterial virulence is a critical factor in disease pathogenesis and treatment failure.

Purpose of the Study:

• To identify novel inhibitors of intracellular Salmonella enterica virulence using a chemical genomics approach.
• To elucidate the molecular targets of identified inhibitors.

Main Methods:

• Chemical genomics screening to identify potential virulence inhibitors.
• In vitro and in vivo assays to evaluate the efficacy of identified compounds.
• Target identification by investigating the effect of inhibitors on bacterial two-component systems.

Main Results:

• Dephostatin was identified as a potent inhibitor of intracellular Salmonella enterica virulence.
• Dephostatin effectively reduces bacterial load in vitro and in vivo.
• The compound targets the SsrA-SsrB and PmrB-PmrA two-component regulatory systems.

Conclusions:

• Dephostatin represents a promising therapeutic candidate for treating Salmonella enterica infections.
• Targeting bacterial two-component systems offers a viable strategy to combat antibiotic resistance.